# US 2009/0269735 A1 · Sample pretreatment solution for immunological test and method for using the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0269735 A1
- Document ID: US20090269735A1
- Status: Published application
- Kind: A1
- Application number: 12/497,350
- Filed: 2009-07-02
- Published: 2009-10-29
- Earliest claimed: 2003-06-30
- Assignees: Sysmex Corporation
- Inventors: Takeshi IMOARAI; Motoi FURUTANI; Masako Aki
- Web page: https://patentgrep.com/patent/US20090269735A1

## CPC

- G01N 33/54393: {Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding}
- G01N 33/54388: {based on lateral flow}
- G01N 33/56983: {Viruses}
- G01N 2333/11: Orthomyxoviridae, e.g. influenza virus
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Sample pretreatment solutions for influenza virus tests by immunochromatography are described. Methods detecting influenza virus by immunochromatography using the sample pretreatment solutions and Kits comprising the sample pretreatment solution and an immunochromatographic device are also described.

## Claims

### Claim 1

A method for detecting influenza virus contained in a sample, comprising the steps of:
providing a chromatography test strip for detecting influenza virus and a sample pretreatment solution comprising a surfactant and at least 0.3 M alkali metal ion;
preparing an assay sample by mixing the sample and the sample pretreatment solution; and
detecting influenza virus by assaying the prepared assay sample with the test strip.

### Claim 2 (depends on 1)

The method of claim 1, wherein the test strip comprises a chromatography membrane having an immobilized anti-influenza virus antibody.

### Claim 3 (depends on 2)

The method of claim 2, wherein the test strip comprises colored particles each of which is labeled with anti-influenza virus antibody.

### Claim 4 (depends on 1)

The method of claim 1, wherein the sample is nasal discharge, sputum or throat swab.

### Claim 5 (depends on 1)

The method of claim 1, wherein the assay sample is prepared by mixing the sample and the sample pretreatment solution and filtering the mixture.

### Claim 6 (depends on 1)

The method of claim 1, wherein a concentration of the alkali metal ion ranges from 0.3 M to 2 M.

### Claim 7 (depends on 1)

The method of claim 1, wherein the sample pretreatment solution comprises the alkali metal ion of at least 0.4 M.

### Claim 8 (depends on 1)

The method of claim 1, wherein the sample pretreatment solution comprises the alkali metal ion of at most 1.5 M.

### Claim 9 (depends on 1)

The method of claim 1, wherein the sample pretreatment solution comprises a thiocyanate compound.

### Claim 10 (depends on 9)

The method of claim 9, wherein the sample pretreatment solution comprises the thiocyanate compound at a concentration of not more than 0.1 M.

### Claim 11 (depends on 10)

The method of claim 10, wherein the concentration of the thiocyanate compound ranges from 0.1 M to 1 M.

### Claim 12 (depends on 9)

The method of claim 9, wherein the thiocyanate compound is selected from the group consisting of thiocyanic acid, thiocyanate esters and thiocyanates.

### Claim 13 (depends on 9)

The method of claim 9, wherein the thiocyanate compound is selected from the group consisting of sodium thiocyanate, potassium thiocyanate, ammonium thiocyanate and guanidine thiocyanate.

### Claim 14 (depends on 1)

The method of claim 1, wherein the surfactant comprises a nonionic surfactant.

### Claim 15 (depends on 14)

The method of claim 14, wherein the nonionic surfactant is a polyoxyethylene surfactant.

### Claim 16 (depends on 15)

The method of claim 15, wherein the polyoxyethylene surfactant is selected from the group consisting of polyoxyethylene alkyl phenyl ethers, polyoxyethylene alkyl ethers, polyoxyethylene sorbitan fatty acid esters and polyoxyethylene/polyoxypropylene copolymers.

### Claim 17 (depends on 16)

The method of claim 16, wherein a concentration of the nonionic surfactant ranges from 0.05 to 2 (v/v) %.

### Claim 18 (depends on 1)

The method of claim 1, wherein a concentration of the nonionic surfactant ranges from 0.1 to 0.5 (v/v) %.

### Claim 19 (depends on 1)

A test kit using the method of claim 1, comprising the sample pretreatment solution comprising the chromatography test strip and the sample pretreatment solution.

### Claim 20 (depends on 19)

The test kit of claim 19, wherein the test strip comprises a chromatography membrane having an immobilized anti-influenza virus antibody, and colored particles each of which is labeled with anti-influenza virus antibody.
